The FDA is about two years away from approving psilocybin and MDMA for treating PTSD, but most of the general public has been in the dark. Read More

Modern society is rediscovering plants used for ancient spiritual ceremonies. Gaining prominence is the psychedelic drug, ayahuasca. Read More

The increasingly popular practice of ingesting small doses of psychedelics to unleash creativity confers exciting investment opportunities. Read More

New York state and city have taken huge strides to mainstream marijuana, catalyzing cannabis expansion for the rest of the nation. Read More

We’re witnessing a renaissance in psychedelics research. The ramifications are profound for medicine, society, and investors. Read More

Research into LSD, psilocybin, and other psychedelics is accelerating, as biotech firms race to develop new drugs based on these substances. Read More

The U.S. House just passed amendments to expedite the use of psychedelics to treat addicted and traumatized vets and active military members. Read More

Huge coastal states aren’t the only places where cannabis is making headlines. Let’s turn to recent events in the Midwest. Read More

Pot sales soared during the July 4 festivities this year, as weed consumption becomes increasingly popular during the holidays. Read More

Despite the rise of a wide variety of new cannabis products, the most popular form remains traditional, smokeable flower. Read More